Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions
Yin P. Hung(Harvard University), Marina Vivero(Brigham and Women's Hospital), Rachel K. Putman(Brigham and Women's Hospital), Hiroto Hatabu(Harvard University), Mizuki Nishino(Brigham and Women's Hospital), Lynette M. Sholl(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Tetsuro Araki(Brigham and Women's Hospital), Ezra R. Miller(Pulmonary and Critical Care Associates)
Cited by 33
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
|JAMA Oncology|2016|750
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701